Little Green Pharma (ASX: LGP) is poised to significantly capitalise on a major amendment to the French health security bill, paving the way for a substantial … [Read more...]
The Market Limited (ASX: MKT) has announced that Gumtree Cars, a division of wholly owned subsidiary, Gumtree AU Pty Ltd, has launched a new Instant Cash Offer … [Read more...]
Australian-based bio-separations and reproductive biotechnology company Memphasys Limited (ASX: MEM) is preparing to undertake a capital raising via a placement … [Read more...]
Global semiconductor developer BluGlass Limited (ASX: BLG) has signed a US$1.775 million contract with North Carolina State University (NCSU) for BluGlass’ … [Read more...]
SRJ Technologies Group (ASX: SRJ) has been awarded two contracts with US-based companies, marking SRJ’s entrance to the US market. A contract has been … [Read more...]
Biopharmaceutical development company Neurotech International (ASX: NTI) has received Human Research Ethics Committee (HREC) approval to extend the current … [Read more...]
PharmAust Limited (ASX: PAA) has confirmed that all patients have completed its Phase 1 MEND Study of monepantel (MPL) for motor neurone disease (MND/ALS) and … [Read more...]
Cyclopharm Limited (ASX: CYC) reports that Duke University Hospital has signed the first commercial contract for the use of Technegas in the United States. … [Read more...]
AML3D Limited (ASX: AL3) has been awarded a manufacture contract for the provision of a test part for the purpose of ASC Shipbuilding contract to design and … [Read more...]
DUG Technology’s (ASX: DUG) first shipment of our US$7 million worth of new compute has landed at our data centre in Houston, with the remainder expected to … [Read more...]
Smart building materials company ClearVue Technologies Limited (ASX:CPV) has entered the Singapore market through a manufacturing and distribution agreement … [Read more...]
Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company, is pleased to announce its MAST (Metastatic Advanced Solid Tumours) clinical program … [Read more...]